Stay updated on Emricasan for Decompensated NASH Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.

Latest updates to the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision metadata now shows Revision: v3.6.6, indicating a minor update to the page's version history rather than substantive changes to the study details.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.6.5 appears in the page footer, replacing the previous v3.6.4. This indicates a minor platform/template update for the study record.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page's revision label in the footer was updated from v3.6.3 to v3.6.4, indicating a small site update.SummaryDifference0.0%

- Check55 days agoChange DetectedSteatotic Liver Disease has been added to the glossary to reflect updated terminology for liver fat-related conditions used on this study page. Fatty Liver Disease has been removed from the glossary.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page's revision label updates from v3.6.2 to v3.6.3, indicating a small platform/template update rather than changes to study information.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page now displays the updated Revision: v3.6.2, replacing the prior Revision: v3.6.0.SummaryDifference0.0%

Stay in the know with updates to Emricasan for Decompensated NASH Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.